Locoregional Therapy for Intact Primary Tumor in De Novo Stage IV Breast Cancer Reply

Article Oncology

Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108)

Seema A. Khan et al.

Summary: Early locoregional therapy for the primary site did not improve survival in patients with metastatic breast cancer, but it was associated with improved locoregional control without impacting overall quality of life.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Add to Collection

Review Oncology

Primary-Site Local Therapy for Patients with De Novo Metastatic Breast Cancer: An Educational Review

Seema Ahsan Khan et al.

Summary: The current evidence fails to support the effectiveness of the paradigm guiding the management of de novo metastatic breast cancer.

ANNALS OF SURGICAL ONCOLOGY (2022)

Add to Collection

Letter Oncology

Locoregional Therapy for Intact Primary Tumor in De Novo Stage IV Breast Cancer

Atilla Soran et al.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Add to Collection

Article Surgery

Primary Surgery with Systemic Therapy in Patients with de Novo Stage IV Breast Cancer: 10-year Follow-up; Protocol MF07-01 Randomized Clinical Trial

Atilla Soran et al.

Summary: The study found that patients diagnosed with de novo stage IV breast cancer who underwent locoregional treatment followed by systemic therapy had a higher overall survival rate at the end of the 10-year follow-up period compared to those who received only systemic therapy.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2021)

Add to Collection

Article Oncology

Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01

Atilla Soran et al.

ANNALS OF SURGICAL ONCOLOGY (2018)

Add to Collection

Article Oncology

Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial

Rajendra Badwe et al.

LANCET ONCOLOGY (2015)

Add to Collection

Article Medicine, General & Internal

Modified intention to treat reporting in randomised controlled trials: systematic review

Iosief Abraha et al.

BMJ-BRITISH MEDICAL JOURNAL (2010)

Add to Collection

Locoregional Therapy for Intact Primary Tumor in De Novo Stage IV Breast Cancer Reply

Related references

Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108)

Primary-Site Local Therapy for Patients with De Novo Metastatic Breast Cancer: An Educational Review

Locoregional Therapy for Intact Primary Tumor in De Novo Stage IV Breast Cancer

Primary Surgery with Systemic Therapy in Patients with de Novo Stage IV Breast Cancer: 10-year Follow-up; Protocol MF07-01 Randomized Clinical Trial

Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01

Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial

Modified intention to treat reporting in randomised controlled trials: systematic review

Export Citation

Share Paper